NLRP3 and metabolic dysfunction-associated steatotic liver disease: Additionally, we observed that treatment with PcP extract alleviated pyroptosis in rats with NAFLD, as evidenced by a reduction in caspase‐1 activity and NLRP3, GSDMD/N, IL‐1β, and IL‐18 levels.